tafinlar® (dabrafenib) mekinist® (trametinib) mechanism of action for advanced melanoma
Published 2 years ago • 3K plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
2:12
phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
0:54
activity of dabrafenib/trametinib combo in patients with melanoma brain metastases
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
4:24
dabrafenib/trametinib/pembrolizumab for advanced melanoma: update from keynote-022
-
1:49
combi-ad: dabrafenib plus trametinib in advanced melanoma
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) with mekinist (trametinib) fo...
-
1:35
dabrafenib - tafinlar in a nutshell.
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
5:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) in combination with mekinist ...
-
5:13
dabrafenib plus trametinib improves melanoma patients’ survival
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
6:51
dabrafenib and trametinib plus pembrolizumab for braf-mutant melanoma